Krause, S.; Kuckelkorn, U.; Dörner, T.; Burmester, G-R; Feist, E.; Kloetzel, P-M
Immunoproteasome subunit LMP2 expression is deregulated in Sjögren's syndrome but not in other autoimmune disorders.
In: Annals of the Rheumatic Diseases, Vol. 65, No. 8: pp. 1021-1027
Background: The proteasome system has a pivotal role in the control of the immune response, which suggests that it might be involved in the pathogenesis of autoimmune disorders.Objective: To investigate the expression profile of selected proteasomal genes in human peripheral blood mononuclear cells in patients with a variety of autoimmune diseases compared with healthy subjects.Methods: Real time quantitative RT-PCR was used to analyse the mRNA expression pattern of the proteasome activator subunits PA28\textgreeka and PA28\textgreekb and of constitutive proteasome and interferon-\textgreekg-inducible immunoproteasome subunits in peripheral blood mononuclear cells. Simultaneously, protein expression of selected proteasome subunits was quantified by immunoblotting.Results: Under systemic inflammatory conditions the proteasome subunits LMP2 (\textgreekb1i), LMP7 (\textgreekb5i), MECL1 (\textgreekb2i), and PA28\textgreeka were expressed abundantly at the protein level in the vast majority of systemic autoimmune disorders. However, simultaneous mRNA and protein quantification showed a characteristic proteasome expression signature in primary Sjögren's syndrome. At the transcript level, the interferon-\textgreekg-responsive subunits LMP2 (\textgreekb1i), MECL1 (\textgreekb2i), and the proteasome activator subunit PA28\textgreeka were markedly up regulated. In contrast, LMP2 (\textgreekb1i) deficiency was evident at the protein level, indicating deregulation of proteasome expression in Sjögren's syndrome.Conclusions: These data provide evidence for a regulatory defect in the proteasome system in human autoimmune disorders, pointing to a unique role for LMP2 (\textgreekb1i) in the pathogenesis of primary Sjögren's syndrome.